Pulmonary hypertension due to chronic lung disease: Updated Recommendations of the Cologne Consensus Conference 2011

International Journal of Cardiology

Volumn 154, Issue SUPPL. 1, 2011, Pages

  Hoeper, Marius M ^a   Andreas, Stefan ^b   Bastian, Andreas ^c   Claussen, Martin ^d   Ghofrani, H Ardeschir ^e   Gorenflo, Matthias ^f   Grohé, Christian ^g   Günther, Andreas ^h   Halank, Michael ⁱ   Hammerl, Peter ^b   Held, Matthias ^j   Krüger, Stefan ^k   Lange, Tobias J ^l   Reichenberger, Frank ^e   Sablotzki, Armin ^m   Staehler, Gerd ⁿ   Stark, W ^o   Wirtz, Hubert ^p   Witt, Christian ^q   Behr, Jürgen ^r  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Clinic for Pulmonary Disorders   (Germany)

^c Marien Hospital Kassel   (Germany)

^d KRANKENHAUS GROSSHANSDORF   (Germany)

^e UNIVERSITY HOSPITAL GIESSEN   (Germany)

^f UZ Leuven Campus Gasthuisberg ^*  (Belgium)

^g Clinic for Respiratory Medicine   (Germany)

^h JUSTUS LIEBIG UNIVERSITY   (Germany)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^j Department of Internal Medicine   (United States)

^k UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^l UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^m Klinikum St Georg   (Germany)

ⁿ Löwenstein Hospital   (Israel)

^o Theresien Hospital Mannheim   (Germany)

^p UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^q CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^r RUHR UNIVERSITY BOCHUM   (Germany)

more..

Author keywords

COPD; Fibrosis, pulmonary; Hypertension, pulmonary; Lung disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BOSENTAN; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; PLACEBO; SILDENAFIL;

BLOOD GAS ANALYSIS; BLOOD VESSEL REACTIVITY; CARDIOLOGY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL CLASSIFICATION; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; EUROPE; GERMANY; HEALTH CARE PLANNING; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; INTERSTITIAL LUNG DISEASE; LABORATORY TEST; LONG TERM CARE; LUNG ARTERY PRESSURE; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG SCINTISCANNING; LUNG VENTILATION PERFUSION RATIO; LUNG VOLUME; NORMAL VALUE; OXYGEN THERAPY; PATHOPHYSIOLOGY; PEDIATRIC CARDIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONOLOGY; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME; SYMPTOMATOLOGY; TRANSTHORACIC ECHOCARDIOGRAPHY;

CHRONIC DISEASE; GERMANY; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LUNG; LUNG DISEASES; PRACTICE GUIDELINES AS TOPIC;

EID: 84855381329     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/S0167-5273(11)70492-2     Document Type: Conference Paper

References (41)

1. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009;34:1219-63.
2. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537.
3. Hoeper MM, Ghofrani HA, Gorenflo M, et al. Diagnosis and Treatment of Pulmonary Hypertension: European Guidelines 2009. Pneumologie 2010;64:401-14.
4. Hoeper MM, Barbera JA, Channick RN, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009;54:S85-96.
5. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009;34:888-94.
6. Hoeper MM. The new definition of pulmonary hypertension. Eur Respir J 2009;34:790-1.
7. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008;32:1371-85.
8. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008;31:1357-67.
9. Scharf SM, Iqbal M, Keller C, et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002;166:314-22. (Pubitemid 34864419)
10. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005;127:1531-6. (Pubitemid 46218776)
11. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-52.
12. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007;30:715-21. (Pubitemid 351194832)
13. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005;25:783-8. (Pubitemid 40667674)
14. Weitzenblum E, Hirth C, Ducolone A, et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981;36:752-8. (Pubitemid 12249743)
15. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007;131:650-6. (Pubitemid 46446853)
16. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005;26:586-93. (Pubitemid 41448654)
17. Cottin V, Le Pavec J, Prevot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010;35:105-11.
18. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:189-94. (Pubitemid 40981192)
19. Corte TJ, Wort SJ, Gatzoulis MA, et al. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax 2009;64:883-8.
20. Incalzi RA, Fuso L, De Rosa M, et al. Electrocardiographic signs of chronic cor pulmonale: A negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999;99:1600-5. (Pubitemid 29152928)
21. Tramarin R, Torbicki A, Marchandise B, Laaban JP, Morpurgo M. Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen. Eur Heart J 1991;12:103-11.
22. Torbicki A, Skwarski K, Hawrylkiewicz I, et al. Attempts at measuring pulmonary arterial pressure by means of Doppler echocardiography in patients with chronic lung disease. Eur Respir J 1989;2:856-60. (Pubitemid 19267627)
23. Laaban JP, Diebold B, Zelinski R, et al. Noninvasive estimation of systolic pulmonary artery pressure using Doppler echocardiography in patients with chronic obstructive pulmonary disease. Chest 1989;96:1258-62. (Pubitemid 20000817)
24. Fisher MR, Criner GJ, Fishman AP, et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J 2007;30:914-21. (Pubitemid 351194795)
25. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009;179:615-21.
26. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40. (Pubitemid 36801751)
27. Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic Peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006;173:744-50.
28. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546-52. (Pubitemid 44881214)
29. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;131:493-8. (Pubitemid 15086729)
30. Agusti AG, Barbera JA, Roca J, et al. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990;97:268-75. (Pubitemid 20050657)
31. Barbera JA, Roger N, Roca J, et al. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996;347:436-40. (Pubitemid 26054069)
32. Simonneau G, Escourrou P, Duroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981;304:1582-5. (Pubitemid 11122507)
33. Domenighetti GM, Saglini VG. Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease. Chest 1992;102:708-14.
34. Agostoni P, Doria E, Galli C, Tamborini G, Guazzi MD. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;139:120-5. (Pubitemid 19030432)
35. Dupuis J, Hoeper MM. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008;31:407-14.
36. Wilkins MR, Wharton J, Grimminger F, Ghofrani HA. Phosphodiesterase inhibitors for the treatment of pulmonary hypertension. Eur Respir J 2008;32: 198-209.
37. Olschewski H, Gomberg-Maitland M. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008;31:801-901.
38. Schulz R, Baseler G, Ghofrani HA, et al. Nocturnal periodic breathing in primary pulmonary hypertension. Eur Respir J 2002;19:658-63. (Pubitemid 34285162)
39. Stolz D, Rasch H, Linka A, et al. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J 2008;32:619-28.
40. Blanco I, Gimeno E, Munoz PA, et al. Hemodynamic and gas exchange effects of sildenafil in patients with COPD and pulmonary hypertension. Am J Respir Crit Care Med 2010;181:270-8.
41. Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman DA, Schwarz M, Anstrom KJ, et al. A controlled trial of sildenafil in advanced idiopathic pulmonary Fibrosis. N Engl J Med 2010;363:620-8.